Scary Slide In Cancer Screening

Doctor holding stethoscope with pink ribbon in front — Photo: vectorfusionart / Shutterstock

A test that still carries the federal government’s highest recommendation grade is going undone by a growing share of American women, even as the guidelines for it have gotten easier to follow, not harder.

Quick Take

The U.S. Preventive Services Task Force gives cervical cancer screening its top evidence grade for women ages 21 to 65.
Current guidance calls for a Pap test every three years, not every year, with HPV testing or combined testing allowed every five years after age 30.
National survey data show guideline-adherent screening has fallen over the past two decades, with steeper drops in rural areas.
A shift toward HPV testing and new self-collection kits may explain part of the drop in traditional Pap test numbers.

What Current Screening Guidance Actually Requires

The Task Force’s 2018 recommendation gives cervical cancer screening a grade A, its strongest rating, for women ages 21 to 65. Women 21 to 29 should get a Pap test every three years. Women 30 to 65 can choose cytology every three years, high-risk HPV testing every five years, or both tests together every five years. The guidance tells women younger than 21 and most women older than 65 with a clean screening history that they do not need routine testing.

That three-to-five-year window matters because it breaks from the old habit of an annual Pap smear many women still assume is the standard. Following the newer interval is not neglecting your health. It reflects what the evidence actually supports, and major women’s health organizations endorsed the shift when it was finalized.

The Decline Shows Up Across Multiple Data Sources

Separate national surveys point the same direction. One analysis found guideline-adherent screening dropped from 86 percent in 2005 to 73 percent in 2021. Another, using federal behavioral survey data, found adherence falling from 82 percent in 2018 to just 47 percent in 2022, with rural women lagging furthest behind. A third dataset showed screening rates sliding from nearly 39 percent in 2019 to about 21 percent in 2020 during the pandemic, before partially recovering to roughly 35 percent by 2024.

Fewer Pap Tests Does Not Always Mean Less Protection

Not every missed Pap test represents a missed screening. One multi-state study of community health centers found that by 2022, Pap testing alone made up only about 58 percent of all screenings performed, with HPV co-testing filling much of the remaining share. That means some of the reported decline reflects clinics switching to a newer, equally approved method rather than patients skipping care altogether.

Newer options are also expanding who can get screened. The Health Resources and Services Administration updated its guidelines to include self-collected HPV samples, a method that does not require a traditional pelvic exam. The American College of Obstetricians and Gynecologists and the National Cancer Institute both note that patient-collected HPV testing can reach women who face barriers to a clinic visit. A 2025 practice advisory confirmed self-collection using approved kits is now a recognized screening path for women 30 to 65.

Why the Gaps Persist

The American Cancer Society points out that screening rates were already falling for two decades before the pandemic widened the gap further, and rates still have not fully rebounded. One review of pandemic-era data found screening volume for both cervical and breast cancer dropped sharply in the early shutdown months and only partly recovered afterward. Rural women, lower-income women, and those without steady insurance face the steepest climb back to being up to date.

These are not abstract numbers. A missed screening interval can mean a slow-growing, highly treatable cancer goes undetected for years longer than it should. Cervical cancer is one of the few cancers doctors can often catch before it becomes cancer at all, through routine testing that finds precancerous changes early.

What Women Should Do With This Information

Check your own screening history against the current intervals rather than assuming you are due every year. If a clinic visit feels like a barrier, ask whether HPV self-collection is an option in your state or health system. The guidance has not gotten looser. It has gotten smarter, and closing the gap now means fewer late-stage diagnoses later.